This is a type of cancer that is made up of different kinds of tissue growing together. It's called a mixed tumor because it contains multiple cell types.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Malignant Mixed Tumor?
A malignant mixed tumor is a cancer made of more than one type of tumor tissue. The name is used mostly for rare cancers of the salivary glands, the glands that make saliva. The largest of these, the parotid glands, sit in front of and just below each ear, and that is where these tumors most often appear. Most malignant mixed tumors are carcinoma ex pleomorphic adenoma. A pleomorphic adenoma, also called a benign mixed tumor, is the most common noncancerous salivary gland tumor. Occasionally, part of one turns into cancer, usually after it has been present for years. Two other forms are much rarer: carcinosarcoma, an aggressive cancer containing both gland-type and connective-tissue-type cancer cells, and metastasizing mixed tumor, which looks benign under the microscope yet spreads elsewhere in the body. A similar tumor can also arise, very rarely, from sweat glands in the skin. Malignant mixed Mullerian tumor of the uterus or ovary shares part of the name but is a different cancer.
The clearest risk factor for carcinoma ex pleomorphic adenoma is a benign pleomorphic adenoma that has been present for a long time. The chance of cancerous change appears to grow with the years: one estimate puts it at under 2% after five years and up to 10% after fifteen years without treatment. A tumor that has come back after earlier surgery also carries risk, especially after several recurrences, and much of that risk seems to come from how long the tumor tissue has been there. This is one reason surgeons usually recommend removing a pleomorphic adenoma rather than watching it. Beyond that, causes are mostly unknown. Past radiation exposure to the head and neck has been linked to salivary gland cancers in general, but most people with these cancers have no identifiable cause.
The usual first sign is a lump near the ear, under the jaw or inside the mouth. Often it is a lump the person has had for years that suddenly starts to grow, becomes painful or begins to affect the face. A clinician examines the head, neck and mouth, and checks whether the facial muscles still move normally on both sides. Imaging with MRI (magnetic resonance imaging) or CT (computed tomography) shows the tumor's size, whether it has grown into nearby tissue or nerves, and whether lymph nodes look involved. A sample is usually taken with a thin needle (fine-needle aspiration). Because the cancer sits alongside benign tumor tissue, a small needle sample does not always settle the question, and the diagnosis is sometimes confirmed only when the whole tumor is removed and examined. Salivary tumors are among the hardest tumors to classify, so it is reasonable to ask that a pathologist experienced with them review the tissue. The pathologist also reports the cancer's grade and how far it has spread beyond the original benign tumor, which strongly affects treatment and outlook. Scans of the chest or body may be done to check for spread.
Surgery to remove the tumor completely, with a margin of healthy tissue around it, is the main treatment. For a parotid tumor, the surgeon works around the facial nerve, which runs through the gland and controls facial movement. The nerve is preserved whenever possible, but it may need to be removed if the cancer has grown into it. Lymph nodes in the neck may be removed as well (a neck dissection) when they look enlarged or the cancer is high grade. Radiation therapy after surgery is often recommended when the cancer has invaded beyond the original tumor, reached nerves or lymph nodes, or could not be removed with clear margins. It lowers the chance of the cancer returning in the same area, at the cost of side effects such as mouth and taste changes, skin irritation and fatigue, which usually ease within a few months after treatment ends but sometimes persist. For cancer that has spread or cannot be removed, treatment is with medicines. The tumor tissue may be tested for markers such as HER2 (a protein that drives cell growth) or the androgen receptor (a receptor for male-type hormones), which some carcinoma ex pleomorphic adenomas carry; when present, they can open the door to targeted or hormone-blocking treatments. Chemotherapy and clinical trials are other options. Because these cancers are rare, evidence comes from small case series rather than large trials, and care at a center with head and neck cancer experience is valuable.
Outlook varies widely. A cancer that is still largely confined within the original benign tumor, and is completely removed, often has a good prognosis. Cancers that have invaded surrounding tissue, are high grade or have spread to lymph nodes are more likely to come back or spread, most often to the lungs. Across published studies, about six in ten people with carcinoma ex pleomorphic adenoma are alive five years after diagnosis, but those figures mix early and advanced cases and cannot predict an individual's course. Carcinosarcoma tends to behave more aggressively. After parotid surgery, facial weakness can occur. When the nerve was only stretched or bruised, movement usually returns over a few months; if the nerve had to be removed, the weakness is permanent, though rehabilitation and nerve grafting can help. Some people develop Frey syndrome, in which the cheek sweats or flushes while chewing; it can be treated. Follow-up continues for years because recurrence can appear late; one commonly recommended schedule is a check every 6 to 12 months for the first five years, then yearly. Metastasizing mixed tumor in particular can return decades after the first operation.
Arrange a medical evaluation for any new lump near the ear, under the jaw or inside the mouth, even if it is painless. If you have a known pleomorphic adenoma, or had one removed, contact your care team promptly if it starts growing quickly, becomes painful, or is joined by new numbness or weakness of the face, trouble opening the mouth or new lumps in the neck. These changes can signal a turn toward cancer. After treatment, report a new lump, new facial weakness or other new symptoms rather than waiting for the next scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Malignant Mixed Tumor is like, what's helped you, or ask the community a question.